Jim Cramer on DaVita: "Haven't Seen That Stock Do That Well In This Long"

DaVita Inc. (NYSE:DVA) is one of the S&P 500 stocks that Jim Cramer shared his take on. Cramer highlighted the reason for the company’s rally in February, as he said:

Now, there were a couple non-data center stories, too. The third-best performer in the S&P last month was DaVita. It’s a medical technology company, best known for its kidney dialysis machines. It had a terrible year in 2025, down 24%, but they reported a terrific quarter last month, and the stock caught fire, which is how it finished February up 43%. Haven’t seen that stock do that well in this long. As was the case with Dell, I think this was a situation where the analysts and the investors simply got too negative about the story. So when it turned out that things weren’t as bad as they thought, the stock soared.

DaVita Inc. (NYSE:DVA) delivers kidney dialysis treatment through outpatient centers, hospitals, and home-based care, supported by laboratory testing and physician services.

While we acknowledge the potential of DVA as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now.

Disclosure: None.  Follow Insider Monkey on Google News.